Đang chuẩn bị liên kết để tải về tài liệu:
Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: A non-randomized interventional clinical study

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Microvascular invasion (MVI) is considered to be one of the important prognostic factors that affect postoperative recurrence in patients with hepatocellular carcinoma (HCC) with variable results across their treatment options. | Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion A non-randomized interventional clinical study

TÀI LIỆU LIÊN QUAN

Impact of different surgical and postoperative adjuvant treatment modalities on survival of sinonasal malignant melanoma

Adjuvant chemotherapy versus chemoradiotherapy for small cell lung cancer with lymph node metastasis: A retrospective observational study with use of a national database in Japan

Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: A population-based study

Safety and feasibility of adjuvant chemotherapy with S-1 in Japanese breast cancer patients after primary systemic chemotherapy: A feasibility study

Evaluation of the prognostic impact of postoperative adjuvant radiotherapy on head and neck mucosal melanoma: A meta-analysis

Does chemotherapy or radiotherapy affect the postoperative complication in breast cancer patients who underwent immediate breast reconstruction with tissue expander

Sciatic lateral popliteal block with clonidine alone or clonidine plus 0.2% ropivacaine: Effect on the intra-and postoperative analgesia for lower extremity surgery in children: A randomized prospective controlled study

Dexmedetomidine infusion as an analgesic adjuvant during laparoscopic сholecystectomy: A randomized controlled study

Postoperative radiotherapy is effective in improving survival of patients with stage pIII-N2 non-small-cell lung Cancer after pneumonectomy

Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial – PACHA-01 (NCT02494973)
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.